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ground, yet. Profiles of differentially expressed genes obtained by 
microarrays are overlapping with those obtained by subtractive 
hybridizations. The validity of either technique was confirmed by 
semiquantitative RT-PCR. Thus, a pattern of genes was generat- 
ed, which is preferentially expressed in OA. Such patterns could 
be of diagnostic value and contribute to the characterization of 
the pathogenesis of chronic joint diseases. 
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In healthy articular cartilage chondrocytes remain a stable phe- 
notype and maintain their extraceltular matrix. In osteoarthritis 
(OA), however, very little is known about he fate of articular chon- 
drocytes during the progression of the disease. Previously we 
have shown that chondrocytes in the upper zone of OA cartilage 
express markers of hypertrophy and undergo apoptotic changes 
(Kirsch eta., 2000 Osteoarthritis & Cartilage 8:294-302). In this 
study, we examined the expression of syndcan-3, a marker of 
early chondrocyte differentiation, and annexin VI, a marker of late 
chondrocyte differentiation, in embryonic growth plate cartilage 
and normal and OA human articular cartilage. While syndecan 3 
was exclusively expressed in the proliferative zone of growth 
plate cartilage, annexin VI immunostaining was restricted to the 
hypertrophic and mineralizing zones of growth plate cartilage. 
Approximately 20% of chondrocytes were immunopositive for 
syndecan 3 in normal human articular cartilage, the number of 
syndecan 3-expressing chondrocytes increased to more than 
80% of cells in the upper zone of severely affected OA cartilage. 
Similarly, the number of annexin VI and alkaline phosphatase- 
expressing cells significantly increased in the upper cartilage 
zone during the progression of OA. Double labeling experiments 
with antibodies against syndecan 3 and annexin VI revealed 
chondrocytes, which expressed only syndecan 3, and cells which 
expressed both syndecan 3 and annexin VL These results indi- 
cate that the expression of early (syndecan 3) and late differenti- 
ation markers (annexin Vl, alkaline phosphatase) is activated in 
chondrocytes of OA cartilage. 
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Aim of the study: To analyze the correlation of degenerative 
osteoarthritis with and without synovitis and CD44H, sCD44v5 
and sCD44v6 iso forms in knee joint synovial fluid. 
Material and Methods: Synovial fluid from 52 patients with dif- 
ferant grades of primary osteoarthritis of the knee joint with and 
without synovitis was collected during surgical procedures 
including arthroscopy or primary total knee arthroplasty. ELI SA- 
Kits CD44H, sCD44v5 and sCD44v6 were used to analyze the 
concentrations. 
Results: The osteoarthritis grading was in average 3.5 for 
Keltgren. The data distribution shows a decreased (not significant 
0.05) synovial concentration of all CD44 isoforms with higher 
osteoarthritis grading. All isoforms show higher synovial fluid lev- 
els in osteoarthritis and synovial inflammation than in osteoarthri- 
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tis without synovitis (CD44H p=0.00035; CD44v5 p= 0.150 10; 
CD44v6 p=0.01337). Correlation between the Keligren score and 
CD44 values were found only for CD44v6. 
Conclusion: The catabolic effect on articular cartilage loss over 
time is clinically and radiologically represented in the grade of 
osteoarthritis, but altered CD44 isoform synovial fluid levels of the 
knee joint do not reflect a certain grade of knee osteoarthritis. 
Synovial inflammation of the human osteoarthritic knee joint is 
correlated with CD44H and CD44v6, but not with CD44v5 syn- 
ovial fluid levels. 
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Background: With the emergence of effective structure-modify- 
ing treatments for ostecarthritis (OA), biochemical markers could 
be used to monitor response to therapy. 
Objective: To investigate whether baseline values and 1-year 
changes in biochemical markers of bone and cartilage turnover 
[serum osteocalcin (OC), urine PyridinoUne/Creatinine ratio (PYD), 
urine Deoxypyridinoline/creatinine ratio (DPD), serum hyaluronic 
acid (HA), serum keratan sulfate (KS), and serum cartilage 
oligomeric matrix protein (COMP)] predict the 3-year structural 
progression of knee OA in patient treated with glucosamine sul- 
fate. 
Methods: Data were derived from a cohort of 106 individuals cor- 
responding to the treated arm of a double-blind placebo-con- 
trolled trial having showed the role of 1500 mg of gtucosarnine 
sulfate as a disease-modifying drug in OA. Joint space width 
(JSW) of the medial compartment of the tibio-femoral joint was 
assessed by digital image analysis with a validated computerized 
algorithm (mean JSW) and with a graduated magnifying lens 
(minimal JSW). 
Results: No marker at baseline was correlated with the 3-year 
changes in mean or minimal JSW. However, the 1-year changes 
(values at 12-month - values at baseline) in KS were significantly 
correlated with 3-year changes in minimal JSW (r = 0.28, p = 
0.02). In patients with 1-year changes in KS above the median p 
34.7 ngE/ml), joint space increased over 3-year by [mean (SD)] 
0.35 (0.93) mm while patients with changes in KS below the value 
(1~ 34.7 ngE/ml) had a mean joint space narrowing of 0.16 (0.82) 
mm. Difference between the two groups is statistically significant 
(p = 0.02). 
Conclusion. We conclude that short-term (1 -year) changes in KS 
levels predict long-term (3-year) clinical and radiological evolution 
of knee osteoarthritis in patients treated with glucosamine sulfate. 
